Odan-Valproic Acid 250 mg (Valproic Acid (Sodium Valproate) SOLUTION) 250 MG

ODAN-Valproic Acid 250 MG is an oral solution used for managing certain types of seizures and mood disorders. This medication, containing sodium valproate, is manufactured by Odan Laboratories Ltd. in Canada.

Strength

250 MG

Manufacturer / TM Owner

ODAN LABORATORIES LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ODAN-Valproic Acid 250 MG is primarily used for the treatment of epilepsy and bipolar disorder. It helps to control seizures by affecting the chemicals in the brain that may cause them. Additionally, it is used to manage manic episodes associated with bipolar disorder, helping to stabilize mood.

Side Effects

Common effects of ODAN-Valproic Acid 250 MG may include drowsiness, dizziness, and nausea. Some users might experience weight changes or tremors. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

Precautions & Warnings

ODAN-Valproic Acid 250 MG should be handled with care. It is important to follow the prescribed dosage and administration instructions. Avoid alcohol while using this medication, as it can increase the risk of side effects. Consult a healthcare provider before use if you have liver or pancreatic conditions.

Avoid Interactions

ODAN-Valproic Acid 250 MG may interact with other medications, including certain antiepileptic drugs, antidepressants, and blood thinners. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

ODAN-Valproic Acid 250 MG is used to manage seizures in epilepsy and to treat manic episodes in bipolar disorder.

ODAN-Valproic Acid 250 MG is an oral solution that should be taken as directed by a healthcare provider.

Common side effects may include drowsiness, dizziness, nausea, weight changes, and tremors.

ODAN-Valproic Acid 250 MG may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

ODAN-Valproic Acid 250 MG should be used with caution, especially in individuals with liver or pancreatic conditions. Always consult a healthcare provider before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.